Advertisement
Advertisement

SLDB

SLDB logo

Solid Biosciences Inc

4.43
USD
-0.03
-0.67%
Dec 18, 13:37 UTC -5
Open

Solid Biosciences Inc Profile

About

Solid Biosciences LLC is a life science company. It focuses on developing therapies for Duchenne muscular dystrophy. The company is engaged in developing gene therapies, disease modifying therapies and assistive devices, all targeting the various facets of the DMD. Its product candidate includes SGT-001, a gene transfer candidate which is in Phase I/II clinical trial to restore functional dystrophin protein expression in patients' muscles. Solid Biosciences LLC is headquartered in Cambridge, Massachusetts.

Info & Links

CEO

Alexander Cumbo

Headquarters

500 RUTHERFORD AVENUE,THIRD FLOOR
CHARLESTOWN, MA 02129, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.solidbio.com

Auditor

PricewaterhouseCoopers LLP

Share holders

57

Employees

88

Solid Biosciences Inc Statistics

Valuation Measures

Market Capitalization2

177.02M

Enterprise Value

113.99M

Enterprise Value/EBITDA(ttm)

-1.00

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.13

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-58.75%

Return on Invested Capital(ttm)

-59.86%

Return on Assets(ttm)

-47.84%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-113.86M

Net Income Available to Common(ttm)

-102.44M

Diluted EPS(ttm)

-3.04

Share Statistics

Beta (5Y Monthly)

2.01

52-Week Change

28.78%

S&P 500 52-Week Change

27.86%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

39.95M

Dividend Yield

0.00%

Float4

34.51M

% Held by Insiders

13.63%

% Held by Institutions

81.46%

Balance Sheet

Total Cash(mrq)

171.12M

Total Cash Per Share(mrq)

4.28

Total Debt(mrq)

1.36M

Total Debt/Equity(mrq)

0.81%

Current Ratio(mrq)

7.85%

Quick Ratio(mrq)

7.85%

Book Value Per Share(mrq)

4.29

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.70

Free Cash Flow(ytd)

-70.82M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement